Pepperstone vs Equiti: UAE comparison
Compare the contracting entity, permissions, platforms and limitations with linked primary evidence.
| What to compare | PepperstoneProfile & sources → | EquitiProfile & sources → |
|---|---|---|
| Legal entity | Pepperstone Financial Services (DIFC) Limited | Equiti Securities Currencies Brokers LLC |
| Service scope | UAE arranging entity | UAE trading entity |
| Reported regulator | DFSA | CMA |
| Licence reference | F004356 · arranging deals | 20200000026 (Category 1); 20200000352 (Category 5) |
| Licence evidence | Regulator record | Broker disclosure |
| Published platforms | Pepperstone, MT4, MT5, TradingView, cTrader | MT4, MT5 |
| Published funding minimum | US$10 | Unconfirmed |
| AED base account | Unconfirmed | Unconfirmed |
| Swap-free terms | Unconfirmed | Unconfirmed |
| Live-account testing | Not performed | Not performed |
How to interpret the difference
Pepperstone
Pepperstone’s UAE account pages distinguish Standard pricing from Razor pricing. Standard forex pricing includes a spread markup; Razor uses raw spreads plus commission. A comparison should use the same instrument, platform, trade size and holding period rather than a headline minimum spread.
The UAE platform page lists MT4, MT5, cTrader, TradingView and Pepperstone’s own platform. The account page says TradingView is available for Razor, while the Standard list omits it. It states a minimum funding amount of US$10 or local equivalent, rather than an obligation to fund an account.
Check the sources and limitations →Equiti
Equiti’s UAE legal page identifies Category 1 permissions for international-market brokerage, OTC derivatives and spot currencies, alongside a separate Category 5 introduction/promotion permission. It describes its service as execution only. Match the precise legal name and permission against the current regulator record.
The UAE platform page offers MT4 and MT5. Compare the instrument specifications, commission model and bank-transfer route for the particular account offered to you. We have not assigned a lowest-cost or best-execution award without comparable measured evidence.
Check the sources and limitations →